<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02246777</url>
  </required_header>
  <id_info>
    <org_study_id>ALJ-P2013-1</org_study_id>
    <secondary_id>UMIN000013243</secondary_id>
    <nct_id>NCT02246777</nct_id>
  </id_info>
  <brief_title>Alcon Ex-PRESS™ Glaucoma Filtration Device in Japanese Patients</brief_title>
  <official_title>Assessment of Efficacy and Safety of the Filtration Surgery for Normal Tension Glaucoma Using Ex-PRESS</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alcon Research</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alcon Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the efficacy and safety of the Alcon Ex-PRESS™
      Glaucoma Filtration Device (Ex-PRESS) in Japanese patients with normal tension glaucoma.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 26, 2014</start_date>
  <completion_date type="Actual">October 24, 2016</completion_date>
  <primary_completion_date type="Actual">October 24, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean intraocular pressure (IOP)</measure>
    <time_frame>Up to Month 12</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of patients with IOP lowering rate of 20% or more from baseline up to Month 12</measure>
    <time_frame>Up to Month 12</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of patients receiving drug therapy for glaucoma necessary to maintain the IOP</measure>
    <time_frame>Up to Month 12</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of patients receiving secondary surgical treatment (including laser therapy) necessary to maintain the IOP</measure>
    <time_frame>Up to Month 12</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">37</enrollment>
  <condition>Glaucoma</condition>
  <arm_group>
    <arm_group_label>Ex-PRESS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ex-PRESS™ Glaucoma Filtration Device, Model P50PL, implanted in the anterior chamber of the study eye during glaucoma surgery intended for the lifetime of the patient</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ex-PRESS™ Glaucoma Filtration Device, Model P50PL</intervention_name>
    <arm_group_label>Ex-PRESS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of normal tension glaucoma.

          -  Indicated for filtration surgery using Ex-PRESS.

          -  Understand and provide Informed Consent.

          -  Other protocol-defined inclusion criteria may apply.

        Exclusion Criteria:

          -  Women who are pregnant, lactating, or planning to be pregnant during the study period.

          -  Diagnosis of angle closure glaucoma or secondary glaucoma.

          -  History of glaucoma surgery.

          -  Ophthalmologic surgery within the past 6 months.

          -  Difficulty with applanation tonometry measurement.

          -  Corneal dystrophy.

          -  Infectious/non-infectious conjunctivitis, keratitis, or uveitis in either eye.

          -  Severe blepharitis or dry eye.

          -  History of metal allergy.

          -  Other protocol-defined exclusion criteria may apply.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Senior Manager, Phase IV</last_name>
    <role>Study Director</role>
    <affiliation>Alcon Japan, Ltd.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Contact Alcon Japan, Ltd for Trial Locations</name>
      <address>
        <city>Tokyo</city>
        <zip>107-0052</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 18, 2014</study_first_submitted>
  <study_first_submitted_qc>September 19, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 23, 2014</study_first_posted>
  <last_update_submitted>April 12, 2017</last_update_submitted>
  <last_update_submitted_qc>April 12, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 13, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Glaucoma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>September 27, 2017</submitted>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

